Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Biol Pharm Bull ; 34(4): 562-6, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21467646

RESUMO

Taxanes, which are widely used in treatment of numerous cancer types, are well-known to induce hypersensitivity reactions (HSR), especially in the case of paclitaxel. Although the cause of the HSR is commonly thought to be a non-immunological direct effect of the diluent which is used to dissolve paclitaxel, some reports suggest the possibility of the presence of an immunological reaction to the common taxane structure. The aim of this study was to establish a method to determine the presence of anti-taxane antibodies in body fluids of patients who have previously received paclitaxel, in order to estimate the risk of the occurrence of HSR to other taxane compounds, such as docetaxel. To prepare an enzyme-linked immunosorbent assay (ELISA) plate for determining taxanes, 10-deacetylbaccatin III (DAB) was first succinylated by use of dimethylaminopyridine and succinic anhydride in dried pyridine. After the succinylation reaction, three different products were obtained, and these were confirmed as 7-succinoyl DAB (7-DAB), 10-succinoyl DAB (10-DAB), and 7,10-disuccinoyl DAB (7,10-DAB) by (1)H-NMR analysis. Each of these three products was conjugated with bovine serum albumin (BSA), and adsorbed on an ELISA plate. By using a commercially available anti-taxane monoclonal antibody as a model antibody, the detection limit of the anti-taxane antibodies on the 7-DAB-BSA-, 10-DAB-BSA-, and 7,10-DAB-BSA-conjugated ELISA plate was estimated as 0.3, 1 and 10 ng/ml, respectively. The ELISA system established in this study may therefore be useful for estimating the risk of HSR to taxanes in a patient prior to the use of these drugs.


Assuntos
Anticorpos/metabolismo , Antineoplásicos Fitogênicos/imunologia , Ensaio de Imunoadsorção Enzimática/métodos , Hipersensibilidade/imunologia , Fitoterapia/efeitos adversos , Taxoides/imunologia , Animais , Anticorpos Monoclonais/metabolismo , Antineoplásicos Fitogênicos/efeitos adversos , Antineoplásicos Fitogênicos/uso terapêutico , Bovinos , Fungos/química , Fungos/imunologia , Humanos , Hipersensibilidade/etiologia , Camundongos , Neoplasias/tratamento farmacológico , Paclitaxel/efeitos adversos , Paclitaxel/imunologia , Paclitaxel/uso terapêutico , Fatores de Risco , Taxoides/efeitos adversos , Taxoides/uso terapêutico , Taxus/química , Taxus/imunologia , Taxus/microbiologia
2.
Intern Med ; 49(16): 1813-6, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20720365

RESUMO

A 73-year-old woman developed subacute meningitis-retention syndrome (MRS), dermatitis, and latent pneumonitis likely due to the herbal medicines Shinbu-Tou and Rikkunshi-Tou. The responsible site of lesions for urinary retention seemed to be the spinal micturition pathways and, to a lesser extent, the sacral spinal cord. All of her clinical manifestations were successfully ameliorated within three weeks of discontinuation of the herbal remedies.


Assuntos
Medicamentos de Ervas Chinesas/efeitos adversos , Meningite/induzido quimicamente , Meningite/diagnóstico , Retenção Urinária/induzido quimicamente , Retenção Urinária/diagnóstico , Idoso , Toxidermias/complicações , Toxidermias/diagnóstico , Feminino , Humanos , Meningite/complicações , Síndrome , Retenção Urinária/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA